PVI

Pura Vida Investments Portfolio holdings

AUM $16.6M
1-Year Return 3.82%
This Quarter Return
+18.39%
1 Year Return
-3.82%
3 Year Return
-0.02%
5 Year Return
+29.84%
10 Year Return
+256.58%
AUM
$511M
AUM Growth
+$144M
Cap. Flow
+$50.5M
Cap. Flow %
9.89%
Top 10 Hldgs %
44.63%
Holding
131
New
33
Increased
21
Reduced
22
Closed
15

Top Buys

1
ATRC icon
AtriCure
ATRC
$13.3M
2
LHCG
LHC Group LLC
LHCG
$11.6M
3
CNMD icon
CONMED
CNMD
$7.91M
4
LIVN icon
LivaNova
LIVN
$7.29M
5
IMVT icon
Immunovant
IMVT
$6.59M

Top Sells

1
STAA icon
STAAR Surgical
STAA
$8.07M
2
ADPT icon
Adaptive Biotechnologies
ADPT
$6.21M
3
REGN icon
Regeneron Pharmaceuticals
REGN
$5.48M
4
XLRN
Acceleron Pharma Inc.
XLRN
$5.36M
5
DXCM icon
DexCom
DXCM
$5.15M

Sector Composition

1 Healthcare 78.26%
2 Industrials 2.82%
3 Energy 2.26%
4 Consumer Discretionary 0.62%
5 Consumer Staples 0.32%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
SRACU
76
DELISTED
Stable Road Acquisition Corp. Unit
SRACU
$748K 0.07%
74,070
– –
ZYME icon
77
Zymeworks
ZYME
$1.14B
$739K 0.07%
+20,500
New +$739K
SRRA
78
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$229K 0.02%
18,940
– –
ATXS icon
79
Astria Therapeutics
ATXS
$424M
$119K 0.01%
3,085
+67
+2% +$2.58K
FPRX
80
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$68K 0.01%
+11,100
New +$68K
MAPSW icon
81
WM Technology, Inc. Warrants
MAPSW
$3.67M
$25K ﹤0.01%
50,000
– –
ABEO icon
82
Abeona Therapeutics
ABEO
$353M
– –
-7,454
Closed -$391K
ABT icon
83
Abbott
ABT
$231B
– –
0
– –
AUPH icon
84
Aurinia Pharmaceuticals
AUPH
$1.63B
– –
-98,913
Closed -$1.44M
AXSM icon
85
Axsome Therapeutics
AXSM
$6.25B
– –
0
– –
BMY icon
86
Bristol-Myers Squibb
BMY
$96B
– –
0
– –
COO icon
87
Cooper Companies
COO
$13.5B
– –
0
– –
CRBP icon
88
Corbus Pharmaceuticals
CRBP
$121M
– –
-4,000
Closed -$629K
CSTL icon
89
Castle Biosciences
CSTL
$683M
– –
-110,899
Closed -$3.31M
EOLS icon
90
Evolus
EOLS
$495M
– –
-141,442
Closed -$587K
EW icon
91
Edwards Lifesciences
EW
$47.5B
– –
0
– –
FXH icon
92
First Trust Health Care AlphaDEX Fund
FXH
$934M
– –
0
– –
GILD icon
93
Gilead Sciences
GILD
$143B
– –
-50,000
Closed -$3.74M
IHI icon
94
iShares US Medical Devices ETF
IHI
$4.35B
– –
0
– –
INCY icon
95
Incyte
INCY
$16.9B
– –
0
– –
INO icon
96
Inovio Pharmaceuticals
INO
$148M
– –
0
– –
IRTC icon
97
iRhythm Technologies
IRTC
$5.82B
– –
0
– –
IWM icon
98
iShares Russell 2000 ETF
IWM
$67.8B
– –
0
– –
KALA icon
99
KALA BIO
KALA
$102M
– –
0
– –
LLY icon
100
Eli Lilly
LLY
$652B
– –
0
– –
2 3
4
5 6